EMA approvals

Market Access

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike

Market Access

The FDA released its overview of 2023 and the drugs it had approved during the year.

News

Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.